Navigation Links
sPLA2 in Medical News

Experimental Drug May Prevent Plaque Buildup

...atherosclerosis are produced when enzymes known as spla2 break down particular molecules in the blood and a...e of The Lancet . "Our study demonstrates that spla2 inhibition produces favorable changes in plasma li...rther study is needed to determine "the effects of spla2 inhibition on reducing atherosclerosis progression...
sPLA2 in Medical Technology

Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome

...-HDL cholesterol - Varespladib's immediate and selective inhibition of spla2 effectively suppressed inflammation following the index event and was furth...nt markers of cardiovascular risk including, a near complete suppression of spla2 activity and mass, clinically meaningful and statistically significant redu...

Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

...d Chief Medical Officer of Anthera Pharmaceuticals, Inc. "We believe a drug that is deemed to be safe and able to suppress inflammation by inhibiting spla2 provides an opportunity for early intervention for patients where current treatment options are limited." "Today's announcement marks an exciting...

Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial

... Phase IIb clinical trial of A-002, for the treatment of cardiovascular disease. In this second study, administration of once-daily A-002 lowered both spla2 and LDL-C levels confirming the positive effects of A-002 treatment seen in the twice-daily PLASMA study (Phospholipase Levels And Serological Markers...

Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

...rvention for a serious inflammatory lung disease with a potent inhibitor of spla2 such as A-001. Worldwide, nearly 200,000 suffer from some form of sickle ce...even the common complications of sickle cell disease. As such, discovery of spla2 as a potential therapeutic target for patients at risk for acute chest synd...

Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease

...g of A-002, suggests that a single daily dose may be sufficient to suppress spla2 for up to 24 hours. We look forward to further exploring this opportunity t...irst half of 2008. Further information about Anthera's clinical trials and spla2 can be found at http://www.PLASMAtrial.com or http://www.anthera.com . ...
sPLA2 in Biological Technology

Anthera Presents Data on Varespladib at ATVB Meeting

...ow-Density Lipoproteins in CHD Patients with Diabetes. -- The Synergistic Inhibition of Atherogenesis in ApoE-/- Mice Between Pravastatin and the spla2 Inhibitor Varespladib (A-002). "We are pleased to see the synergistic effect of Varespladib with statins on plaque reduction, composition and stabil...
Other Tags
(Date:9/30/2014)... 2014 Dynamic health trends, changing ... in the Bread Production industry over the past ... moderate their consumption of a variety of industry ... shrunk the market for white loaf bread and ... by introducing more nutritious products to attract health-conscious ...
(Date:9/30/2014)... September 30, 2014(BRONX, NY)Medications are the leading cause of ... analysis of death certificates from 1999 to 2010, conducted ... and Albert Einstein College of Medicine of Yeshiva ... Journal of Allergy and Clinical Immunology , also ... was particularly high among older people and African-Americans and ...
(Date:9/30/2014)... NV (PRWEB) September 30, 2014 Fat ... nutrition specialist and best-selling author Mike Geary that is helping ... transform their body into a fat-burning machine in less than ... an investigative review. , “In our culture that is ... be hard to decipher what is really fact and fiction ...
(Date:9/30/2014)... Eagan, Minn. (PRWEB) September 30, 2014 ... trips to the apple orchard, pumpkin patch or annual ... season for fast-spreading viruses – like the respiratory infection ... cold in most children, a small percentage – especially ... severe symptoms. Increased concern about the Enterovirus is prompting ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 A group of ... to combat an epidemic that, left unchecked, could create a ... are not headed to Africa. John Rogers, the Executive Director ... North Korea to fight a disease most think mankind conquered ... some 80 years ago is on the comeback in several ...
Breaking Medicine News(10 mins):Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
(Date:9/30/2014)... Institutes of Health (NIH) awarded Lawrence Livermore National ... electrode array system that will enable researchers to ... resolution and scale. , LLNL,s grant-funded project is ... BRAIN (Brain Research through Advancing Innovative Neurotechnologies) ... our understanding of the human mind and uncover ...
(Date:9/30/2014)... of environmental scientists and engineers, led by Clemson ... three-year, $5.25 million grant from the U.S. Department ... to make a direct positive impact on South ... disposal of radioactive contaminants. , "Understanding the scientific ... with environmental aspects of nuclear technologies is imperative ...
(Date:9/30/2014)... New England Journal of Medicine reports positive results ... crizotinib against the subset of lung cancer marked by ... of 50 patients with advanced non-small cell lung cancer ... was 72 percent, with 3 complete responses and 33 ... takes for the disease to resume its growth after ...
Breaking Biology News(10 mins):NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3Researchers get $5.25 million to advance nuclear technologies in South Carolina 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
Other Contents